Past, present and future of end-stage renal disease therapy in the United States

被引:0
|
作者
Uribarri, J [1 ]
机构
[1] CUNY Mt Sinai Sch Med, Dialysis Serv, New York, NY 10029 USA
来源
MOUNT SINAI JOURNAL OF MEDICINE | 1999年 / 66卷 / 01期
关键词
end-stage renal disease; dialysis techniques; progression of renal disease; vascular access; Kt/V;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis was first described and used in 1854 to separate substances in aqueous solution based on different rates of diffusion through a semipermeable membrane. In vivo hemodialysis was performed in animals early in the twentieth century. Hemodialysis was first carried out in patients with acute renal failure in The Netherlands during the Second World War and in the United States in 1948. Repetitive hemodialysis for the treatment of chronic renal failure due to end-stage renal disease had to await the development of an acceptable long-lasting vascular access in 1960. The subsequent successful development of a technique to create an adequate arteriovenous fistula in 1972 permitted the rapid growth of dialysis programs, when the cost of this therapy was largely paid for by Medicare. Equipment has been developed to foster home-care hemodialysis and chronic ambulatory peritoneal dialysis. Enhancements in renal replacement therapy included the availability of recombinant human erythropoietin, calcitriol, and effective antihypertensive drugs. Technical advances in hemodialysis followed the use of bicarbonate dialysate, more biocompatible membranes, membranes of higher porosity, and ultrafiltration. Questions remain regarding the evaluation of the adequacy of dialysis which is to be achieved or prescribed. Careful attention to the management of the patient with progressive chronic renal insufficiency is crucial in dealing with the inevitable onset of uremia and the initiation of dialysis and/or renal transplantation. The cost of renal replacement therefore represents a great societal burden. A better understanding of how to prevent onset and progression of specific nephropathies along with the availability of new and more effective equipment for renal replacement therapy has a high priority.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 50 条
  • [21] THE FUTURE OF THE END-STAGE RENAL-DISEASE PROGRAM
    PAGANINI, EP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1992, 20 (01) : 12 - 15
  • [22] Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States
    Devlin, Amy
    Waikar, Sushrut
    Solomon, Daniel H.
    Lu, Bing
    Shaykevich, Tamara
    Alarcon, Graciela S.
    Winkelmayer, Wolfgang C.
    Costenbader, Karen H.
    ARTHRITIS CARE & RESEARCH, 2011, 63 (12) : 1642 - 1653
  • [23] Polycystic kidney disease at end-stage renal disease in the United States: patient characteristics and survival
    Abbott, KC
    Agodoa, LY
    CLINICAL NEPHROLOGY, 2002, 57 (03) : 208 - 214
  • [24] Incidence trends and mortality in end-stage renal disease attributed to renovascular disease in the United States
    Fatica, RA
    Port, FK
    Young, EW
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (06) : 1184 - 1190
  • [25] SOCIOECONOMIC-STATUS AND END-STAGE RENAL-DISEASE IN THE UNITED-STATES
    YOUNG, EW
    MAUGER, EA
    JIANG, KH
    PORT, FK
    WOLFE, RA
    KIDNEY INTERNATIONAL, 1994, 45 (03) : 907 - 911
  • [26] Projecting the number of patients with end-stage renal disease in the United States to the year 2015
    Gilbertson, DT
    Liu, JN
    Xue, JL
    Louis, TA
    Solid, CA
    Ebben, JP
    Collins, AJ
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (12): : 3736 - 3741
  • [27] Geographic patterns of end-stage renal disease and kidney transplants in the Midwestern United States
    Cao, Yanjia
    Stewart, Kathleen
    Kalil, Roberto
    APPLIED GEOGRAPHY, 2016, 71 : 133 - 143
  • [28] HIV-associated nephropathy and end-stage renal disease in children in the United States
    Tejinder S. Ahuja
    Kevin C. Abbott
    Laura Pack
    Yong-Fang Kuo
    Pediatric Nephrology, 2004, 19 : 808 - 811
  • [29] Increasing Obesity Prevalence in the United States Pediatric End-Stage Renal Disease Population
    Shelton, Brittany
    McWilliams, Deanna M.
    MacLennan, Paul A.
    Reed, Rhiannon D.
    Mostian, Margaux N.
    Sawinski, Deirdre
    Locke, Jayme E.
    TRANSPLANTATION, 2018, 102 : S844 - S844
  • [30] Race and end-stage renal disease in the United States Medicare population: The disparity persists
    Tomson, Charles R. V.
    Foley, Robert N.
    Li, Qi
    Gilbertson, David T.
    Xue, Jay L.
    Collins, Allan J.
    NEPHROLOGY, 2008, 13 (07) : 651 - 656